Navy bean diet for liver health in adults with fatty liver disease
Part of Digestive system clinical trials.
This study tests whether replacing some foods with navy beans can improve liver health in adults with fatty liver disease and mild-to-moderate liver scarring. Participants will eat navy beans daily and complete diet check-ins over the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 75 years
- Diagnosed with fatty liver disease (confirmed by imaging or biopsy)
- Have intermediate-stage liver scarring (F2-F3)
- Body mass index between 25 and 45
- Stable medications for diabetes, blood pressure, cholesterol, or weight for at least 12 weeks
- Willing to eat navy beans and answer diet questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.
This trial tests whether a very low calorie ketogenic diet (a strict low-carb, high-fat diet) can help people with non-alcoholic steatohepatitis (NASH) who have liver scarring. Participants will follow this diet for a year and have two liver biopsies to see if their liver health improves.
This study tests a new drug called ALN-CIDEB for adults with MASH (a type of liver disease linked to metabolic health issues like obesity and diabetes). The drug aims to slow or reverse liver scarring (fibrosis) in people with moderate damage.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
This study tests whether eating peanuts regularly can help improve fatty liver disease (a condition where fat builds up in the liver). You'll be asked to eat peanuts as part of your diet while researchers track changes in your liver health.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.